Key result
Long non-coding RNAs play a pivotal role in the pathogenesis and development of non-alcoholic fatty liver disease by regulating lipid metabolism, inflammation, and insulin resistance.
Why the study?
Non-alcoholic fatty liver disease lacks a fully known mechanism, while emerging evidence implicates long non-coding RNAs in lipid metabolism and hepatic fatty acid deposition.
What is the role of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease?
What is the role of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease?
This review highlights the emerging role of long non-coding RNAs as significant regulatory molecules in the pathogenesis of NAFLD, suggesting their potential as molecular targets for therapy.
Suggests lncRNAs as therapeutic targets in NAFLD; leaves open clinical utility pending interventional trials.
One of the most prevalent diseases worldwide without a fully-known mechanism is non-alcoholic fatty liver disease (NAFLD). Recently, long non-coding RNAs (lncRNAs) have emerged as significant regulatory molecules. These RNAs have been claimed by bioinformatic research that is involved in biologic processes, including cell cycle, transcription factor regulation, fatty acids metabolism, and-so-forth. There is a body of evidence that lncRNAs have a pivotal role in triglyceride, cholesterol, and lipoprotein metabolism. Moreover, lncRNAs by up- or down-regulation of the downstream molecules in fatty acid metabolism may determine the fatty acid deposition in the liver. Therefore, lncRNAs have attracted considerable interest in NAFLD pathology and research. In this review, we provide all of the lncRNAs and their possible mechanisms which have been introduced up to now. It is hoped that this study would provide deep insight into the role of lncRNAs in NAFLD to recognize the better molecular targets for therapy.
No takes yet. Share an insight, caveat, or question.
Shabgah et al. (2021) conducted a review in Non-alcoholic fatty liver disease (NAFLD). Long non-coding RNAs (lncRNAs) was evaluated. Long non-coding RNAs play a pivotal role in the pathogenesis and development of non-alcoholic fatty liver disease by regulating lipid metabolism, inflammation, and insulin resistance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: